Action Contre la Faim Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2016
NCT02751476
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Action Contre la Faim | Action Contre La Faim - France

Active Ingredients

Drugs in Phase 3 Trials (4)

albendazole (Albenza) (1 trial)

azithromycin (zithromax) (1 trial)

fructo-oligosaccharide (1 trial)

inulin (1 trial)

Drugs in Other Trials (1)

water (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malnutrition (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 5